The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B / Kevin Robert Zoellner
Monoamine oxidase B (MAO-B) is a drug target for the treatment of neurodegenerative diseases such as Parkinson's disease. For example, the mechanism-based inactivator of MAO-B, (R)-deprenyl, is frequently used in combination with L-dopa as dopamine replacement therapy in Parkinson's diseas...
Main Author: | Zoellner, Kevin Robert |
---|---|
Published: |
North-West University
2009
|
Online Access: | http://hdl.handle.net/10394/1382 |
Similar Items
-
The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B / Kevin Robert Zoellner
by: Zoellner, Kevin Robert
Published: (2009) -
The synthesis and evaluation of 8-benzyloxycaffeine analogues as inhibitors of monoamine oxidase B / Belinda Strydom
by: Strydom, Belinda
Published: (2012) -
The synthesis and evaluation of 8-benzyloxycaffeine analogues as inhibitors of monoamine oxidase B / Belinda Strydom
by: Strydom, Belinda
Published: (2012) -
The synthesis and evaluation of phenoxymethylcaffeine analogues as inhibitors of monoamine oxidase / Braam Swanepoel
by: Swanepoel, Abraham Johannes
Published: (2013) -
The synthesis and evaluation of phenoxymethylcaffeine analogues as inhibitors of monoamine oxidase / Braam Swanepoel
by: Swanepoel, Abraham Johannes
Published: (2013)